Category Archives: News

SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to …

SOM Biotech attended 3rd “Hard Reg Café” meeting dedicated to the topic of FDA approval for new drugs

Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory Affairs meeting that took place on June 5 at the Barcelona Science Park (www.pcb.ub.edu). The event was organized by the CataloniaBio & HealthTech Regulatory Affairs Workgroup with the support of ACCIÓ (Government of Catalonia). The main objective of the meeting …

SOM Biotech collaborated in the organization of the University of Barcelona Summer Course about Rare Diseases

SOM Biotech collaborated in the organization of the University of Barcelona Summer Course: “Rare Diseases: from the patient to the cure”. Within the framework of the course, Dr. Raúl Insa, SOM Biotech CEO, did a master class included in the module “Pharmaceuticals in rare diseases”. The topic of his speech was: “Repositioning of drugs in …

SOM Biotech participated at Barcelona Biotech Breakfast: Applying Artificial Intelligence in Drug Discovery and Development

Oscar Huertas, Drug Discovery Manager, and Maria Zimina, Business Development Manager of SOM Biotech, participated at DIT Barcelona Biotech Breakfast: Applying AI in Drug Discovery and Development. The event took place at the Parc Cientific de Barcelona on 19th of June 2019. The event included masterclasses in an open panel discussion format with leading British and Catalan speakers …

SOM Biotech at Veeva R&D Summit Europe 2019

Dr. Raúl Insa, SOM Biotech CEO, participated in the Clinical Roundtable at Veeva R&D Summit Europe 2019.  The clinical team of SOM Biotech: Dr. Santiago Esteva and Aileen Ferré, attended the conference sessions organized in the framework of the Summit. The Summit took place in Barcelona last 11-13 June 2019. Veeva R&D Summit Europe is …

SOM Biotech at BIO 2019

SOM Biotech attended the BIO International Convention in Philadelphia last 3-6 June 2019. BIO is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. This year 4.075 companies attended with more than …

SOM Biotech at the International Congress 2019 on Duchenne Muscular Dystrophy and Becker

Dr. Raúl Insa, SOM Biotech CEO, gave a talk on the topic “Repositioning of Utrophin” at the International Congress 2019 on Duchenne Muscular Dystrophy and Becker, an event organized by Duchenne Parent Project España. The Congress took place in Madrid from 7th to 9th of June. The Congress analyzed the different therapeutic strategies that exist …

Interview of SOM Biotech for Labiotech.eu

Dr. Raúl Insa, SOM Biotech CEO, gave an interview to Labiotech.eu, leading digital media covering the European Biotech industry, read by 100000+ monthly visitors. In this interview, Dr. Insa explained the mission of SOM Biotech, advantages of drug repurposing and aspects of drug development for Orphan diseases. SOM Biotech’s CEO also talked about the current …

SOM Biotech will attend the 12th Annual Global Discovery to Development Innovation Forum (GDDIF)

Dr. Luca Signorile, Senior computational chemist at SOM Biotech, will be attending the 12th Annual Global Discovery to Development Innovation Forum (GDDIF) that will take place in Amsterdam on 14th – 15th of May. The Annual GDDIF is the leading pharmaceutical Research & Development summit for pharma decision makers, scientific leaders, and solutions experts. Taking a …

SOM Biotech at TechShare – pre-IPO programme launched by Euronext

Dr. Raúl Insa, SOM Biotech CEO, attended the second campus of the 2018-2019 TechShare programme organized by Euronext and Nova School of Business and Economics (Nova SBE). The event took place on 15th and 16th of March in Lisbon, Portugal. TechShare is an educational and mentoring programme which aims to familiarize the CEOs of Bio-Tech companies with the financial markets. …